Thoughts on Healthcare Markets & Technology
Thoughts on Healthcare Markets & Technology Podcast
How Medicare's 2027 Outpatient Rule Reprices 340B Drugs, Expands Ambulatory Surgery, Cuts Imaging Payments, and Creates Business Opportunities in Clinical Software and Care Delivery
0:00
-6:11

Paid episode

The full episode is only available to paid subscribers of Thoughts on Healthcare Markets & Technology

How Medicare's 2027 Outpatient Rule Reprices 340B Drugs, Expands Ambulatory Surgery, Cuts Imaging Payments, and Creates Business Opportunities in Clinical Software and Care Delivery

Medicare’s 2027 outpatient rule just dropped. The headline is 2.3%. The actual story is four payment changes that hit drugs, surgery, imaging, and clinical software differently, and not always in the direction you’d expect. Thread.

340B drugs: payment shifts from average sales price +6% to -28%. On a $1,000 drug, that’s a drop from $1,060 to $720 in allo…

User's avatar

Continue reading this post for free, courtesy of Trey’s Thoughts on Healthcare.